News

Removing EPO signalling in mouse liver tumors leads to tumor regression along with sensitivity to immunotherapy.
A protein identified nearly 40 years ago for its ability to stimulate the production of red blood cells plays a surprising, ...
A man with a life-threatening peanut allergy is living a near-normal life after taking part in a “life-changing” study which gradually saw him exposed to nuts ...
USC researchers have developed an innovative type of cancer-fighting immune cell, the EchoBack CAR T-cell, that uses focused ...
Mark Litzow, MD, discusses the challenges of using immunotherapy for the treatment of acute lymphoblastic leukemia.
Older adults with cancer respond just as well as younger patients to immune checkpoint inhibitors despite age-related immune ...
Immunotherapy is the use of medicines that help a person’s own immune system find and destroy cancer cells. It can be used to treat some people with liver cancer. An important part of the immune ...
An April 6 article in the WaPo, one of the most recent as the NIH undergoes administrative changes, claims, “A big step forward in cancer therapy has been slowed by layoffs and ...
Male and female participants aged ≥ 18 years at the time of signing the informed consent form (ICF) prior to initiation of any study specific activities/procedures. * Biopsy-proven IgAN diagnosed ...
Planning a trip abroad soon? Choosing the right debit card can make a big difference to your travel budget. Unfortunately, many UK debit cards still charge as much as three per cent in foreign ...
Approval of the Opdivo plus Yervoy combination regimen was based on results from the Phase III CheckMate-8HW trial, which was the largest immunotherapy study in patients with previously untreated, ...